Longeveron® Announces First Quarter 2025 Financial Results and Provides Business Update


MIAMI, May 08, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, today reported financial results for the quarter ended March 31, 2025 and provided a business update.

View post:
Longeveron® Announces First Quarter 2025 Financial Results and Provides Business Update

Related Posts